Search results for "Immune evasion"

showing 10 items of 42 documents

Genetic Variability of Hepatitis C Virus before and after Combined Therapy of Interferon plus Ribavirin

2008

We present an analysis of the selective forces acting on two hepatitis C virus genome regions previously postulated to be involved in the viral response to combined antiviral therapy. One includes the three hypervariable regions in the envelope E2 glycoprotein, and the other encompasses the PKR binding domain and the V3 domain in the NS5A region. We used a cohort of 22 non-responder patients to combined therapy (interferon alpha-2a plus ribavirin) for which samples were obtained before initiation of therapy and after 6 or/and 12 months of treatment. A range of 25-100 clones per patient, genome region and time sample were sequenced. These were used to detect general patterns of adaptation, t…

Genome evolutionHepatitis C virusEvolutionary Biology/Bioinformaticslcsh:MedicineAlpha interferonGenome ViralHepacivirusBiologyVirology/Immune EvasionInterferon alpha-2Viral Nonstructural Proteinsmedicine.disease_causeGenomeAntiviral AgentsEvolution Molecularchemistry.chemical_compoundGenetics and Genomics/Population GeneticsRibavirinmedicineHumanslcsh:ScienceNS5APhylogenyGenetics:CIENCIAS DE LA VIDA::Genética ::Otras [UNESCO]Virology/Antivirals including Modes of Action and ResistanceMultidisciplinaryEvolutionary Biology/Evolutionary and Comparative GeneticsHepatitis C virusRibavirinlcsh:RGenetic VariationInterferon-alphaVirologyComplementarity Determining RegionsHepatitis CVirology/Virus Evolution and SymbiosisRecombinant ProteinsUNESCO::CIENCIAS DE LA VIDA::Genética ::OtrasHypervariable regionchemistryViral evolutionInterferonlcsh:QGenetic variabilityHepatitis C virus; Genetic variability; Interferon; Ribavirin; Combined therapyCombined therapyResearch ArticlePLoS ONE
researchProduct

Evidence of Recombination in Intrapatient Populations of Hepatitis C Virus.

2008

Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future. HCV is characterized by a high level of genetic heterogeneity. Although homologous recombination has been demonstrated in many members of the family Flaviviridae, to which HCV belongs, there are only a few studies reporting recombination on natural populations of HCV, suggesting that these events are rare in vivo. Furthermore, these few studies have focused on recombination between different HCV genotypes/subtypes but there are no reports on the extent of intra-genotype or intra-subtype recombination between viral strains infecting the same patient.…

GenotypeHepatitis C virusHepacivirusPublic Health and Epidemiology/Infectious Diseaseslcsh:MedicineHepacivirusVirology/Immune Evasionmedicine.disease_causeAntiviral AgentsGenetics and Genomics/Population GeneticsGenotypemedicineNS5Alcsh:SciencePhylogenyRecombination GeneticGeneticsLikelihood FunctionsGenomeMultidisciplinaryModels GeneticbiologyGenetic heterogeneitylcsh:RGenetic Variationvirus diseasesRNA virusbiology.organism_classificationGenetics and Genomics/Microbial Evolution and GenomicsVirologyVirology/Virus Evolution and Symbiosislcsh:QComputational Biology/Population GeneticsHomologous recombinationAlgorithmsSoftwareRecombinationResearch Article
researchProduct

Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1.

2013

The immune system should constitute a strong selective pressure promoting viral genetic diversity and evolution. However, HIV shows lower sequence variability at T-cell epitopes than elsewhere in the genome, in contrast with other human RNA viruses. Here, we propose that epitope conservation is a consequence of the particular interactions established between HIV and the immune system. On one hand, epitope recognition triggers an anti-HIV response mediated by cytotoxic T-lymphocytes (CTLs), but on the other hand, activation of CD4(+) helper T lymphocytes (TH cells) promotes HIV replication. Mathematical modeling of these opposite selective forces revealed that selection at the intrapatient l…

Helper T lymphocyteQH301-705.5HIV AntigensEpitopes T-LymphocyteHIV InfectionsImmunodominanceBiologyVirus ReplicationGeneral Biochemistry Genetics and Molecular BiologyEpitopeEvolution Molecular03 medical and health sciencesImmune systemCytotoxic T cellHumansComputer SimulationAmino Acid SequenceBiology (General)BiologyConserved Sequence030304 developmental biologyImmune Evasion0303 health sciencesImmunity CellularGeneral Immunology and MicrobiologyModels Genetic030306 microbiologyGeneral NeuroscienceGenetic VariationViral LoadVirology3. Good healthEpitope mappingHIV AntigensViral replicationImmunologyHost-Pathogen InteractionsSynopsisHIV-1General Agricultural and Biological SciencesAlgorithms
researchProduct

Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion

2015

mRNA reprogramming results in the generation of genetically stable induced pluripotent stem (iPS) cells while avoiding the risks of genomic integration. Previously published mRNA reprogramming protocols have proven to be inconsistent and time-consuming and mainly restricted to fibroblasts, thereby demonstrating the need for a simple but reproducible protocol applicable to various cell types. So far there have been no published reports using mRNA to reprogram any cell type derived from human blood. Nonmodified synthetic mRNAs are immunogenic and activate cellular defense mechanisms, which can lead to cell death and inhibit mRNA translation upon repetitive transfection. Hence, to overcome RNA…

Homeobox protein NANOGCellular Reprogramming TechniquesInduced Pluripotent Stem CellsVaccinia virusFibroblastsBiologyTransfectionLIN28Molecular biologyCell biologyKruppel-Like Factor 4MicroRNAsSOX2KLF4GeneticsHumansMolecular MedicineCellular Reprogramming TechniquesRNA MessengerProgenitor cellInduced pluripotent stem cellMolecular BiologyReprogrammingEndothelial Progenitor CellsImmune EvasionHuman Gene Therapy
researchProduct

Suppression of CD8+ T cell recognition in the immediate-early phase of human cytomegalovirus infection.

2012

Human cytomegalovirus (HCMV) interferes with MHC class I-restricted antigen presentation and thereby reduces recognition by CD8+ T-cells. This interference is mediated primarily by endoplasmic reticulum-resident glycoproteins that are encoded in the US2–11 region of the viral genome. Such a suppression of recognition would be of particular importance immediately after infection, because several immunodominant viral antigens are already present in the cell in this phase. However, which of the evasion proteins gpUS2–11 interfere(s) with antigen presentation to CD8+ T-cells at this time of infection is not known. Here we address this question, using recombinant viruses (RV) that express only o…

Human cytomegalovirusVirulence FactorsvirusesAntigen presentationCytomegalovirusCD8-Positive T-LymphocytesCell LineImmune toleranceViral ProteinsViral Envelope ProteinsAntigenVirologyMHC class IImmune TolerancemedicineHumansCytotoxic T cellImmune EvasionbiologyHistocompatibility Antigens Class IRNA-Binding Proteinsvirus diseasesmedicine.diseaseVirologyCell cultureCytomegalovirus InfectionsImmunologybiology.proteinCD8
researchProduct

Immune evasion proteins gpUS2 and gpUS11 of human cytomegalovirus incompletely protect infected cells from CD8 T cell recognition

2009

AbstractHuman cytomegalovirus (HCMV) encodes four glycoproteins, termed gpUS2, gpUS3, gpUS6 and gpUS11 that interfere with MHC class I biosynthesis and antigen presentation. Despite gpUS2–11 expression, however, HCMV infection is efficiently controlled by cytolytic CD8 T lymphocytes (CTL). To address the role of gpUS2 and gpUS11 in antigen presentation during viral infection, HCMV mutants were generated that expressed either gpUS2 or gpUS11 alone without coexpression of the three other proteins. Fibroblasts infected with these viruses showed reduced HLA-A2 and HLA-B7 surface expression. Surprisingly, however, CTL directed against the tegument protein pp65 and the regulatory IE1 protein stil…

Human cytomegalovirusvirusesAntigen presentationIE1CytomegalovirusCD8-Positive T-LymphocytesVirus ReplicationMajor histocompatibility complexpp65US2Immediate-Early ProteinsViral Matrix ProteinsHLA-B7 AntigenInterferon-gammaViral ProteinsImmune systemViral Envelope ProteinsVirologyHLA-A2 AntigenMHC class ImedicineHumansCytotoxic T cellCells CulturedAntigen PresentationbiologyImmune evasionRNA-Binding Proteinsvirus diseasesbiochemical phenomena metabolism and nutritionPhosphoproteinsmedicine.diseaseVirologyCTL*MutagenesisCTLCytomegalovirus InfectionsMHC class Ibiology.proteinUS11CD8Virology
researchProduct

Distinct immune evasion in APOBEC ‐enriched, HPV ‐negative HNSCC

2020

Immune checkpoint inhibition leads to response in some patients with head and neck squamous cell carcinoma (HNSCC). Robust biomarkers are lacking to date. We analyzed viral status, gene expression signatures, mutational load and mutational signatures in whole exome and RNA-sequencing data of the HNSCC TCGA dataset (n = 496) and a validation set (DKTK MASTER cohort, n = 10). Public single-cell gene expression data from 17 HPV-negative HNSCC were separately reanalyzed. APOBEC3-associated TCW motif mutations but not total single nucleotide variant burden were significantly associated with inflammation. This association was restricted to HPV-negative HNSCC samples. An APOBEC-enriched, HPV-negat…

MaleAPOBECCancer ResearchT-Lymphocytesmedicine.medical_treatment610BiologyCohort Studies03 medical and health sciences0302 clinical medicineGene expressionBiomarkers TumormedicineHumansExomeAPOBEC Deaminasestumor inflammationPapillomaviridaeExomeGeneImmune EvasionInflammationSequence Analysis RNASquamous Cell Carcinoma of Head and NeckPapillomavirus InfectionsAPOBECmutational signatureImmunotherapyMiddle Agedmedicine.diseaseHead and neck squamous-cell carcinomaPhenotypeImmune checkpointddc:Gene Expression Regulation Neoplasticstomatognathic diseasesOncologyHead and Neck Neoplasms030220 oncology & carcinogenesisMutationCancer researchimmune checkpoint inhibitionFemalehead and neck cancerTranscriptome600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und GesundheitInternational Journal of Cancer
researchProduct

CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity.

2014

Abstract Immunoevasive proteins (“evasins”) of human CMV (HCMV) modulate stability and localization of MHC class I (MHC I) molecules, and their supply of antigenic peptides. However, it is largely unknown to what extent these evasins interfere with recognition by virus-specific CD8 T cells. We analyzed the recognition of HCMV-infected cells by a panel of CD8 T cells restricted through one of nine different MHC I allotypes. We employed a set of HCMV mutants deleted for three or all four of the MHC I modulatory genes US2, US3, US6, and US11. We found that different HCMV evasins exhibited different allotype-specific patterns of interference with CD8 T cell recognition of infected cells. In con…

MaleT cellvirusesImmunologyCD1CytomegalovirusCD8-Positive T-LymphocytesMajor histocompatibility complexCell LineAntigenMHC class ImedicineImmunology and AllergyCytotoxic T cellHumansAntigens ViralAllelesImmune EvasionGeneticsAntigen PresentationbiologyHistocompatibility Antigens Class IMHC restrictionCell biologymedicine.anatomical_structureCytomegalovirus Infectionsbiology.proteinFemaleCD8Journal of immunology (Baltimore, Md. : 1950)
researchProduct

Increase in gut microbiota after immune suppression in baculovirus-infected larvae.

2013

Spodoptera exigua microarray was used to determine genes differentially expressed in S. exigua cells challenged with the species-specific baculovirus SeMNPV as well as with a generalist baculovirus, AcMNPV. Microarray results revealed that, in contrast to the host transcriptional shut-off that is expected during baculovirus infection, S. exigua cells showed a balanced number of up- and down-regulated genes during the first 36 hours following the infection. Many immune-related genes, including pattern recognition proteins, genes involved in signalling and immune pathways as well as immune effectors and genes coding for proteins involved in the melanization cascade were found to be down-regul…

MicroarraysApplied MicrobiologyvirusesGut floraTranscriptomesBiology (General)Immune ResponseEffectorViral Immune EvasionMicrobiotaAgricultureGenomicsFunctional GenomicsHost-Pathogen InteractionIntestinesLarvaResearch ArticleQH301-705.5Mechanisms of Resistance and SusceptibilityImmunologyVirulenceBiologySpodopteraSpodopteraImmune SuppressionMicrobiologydigestive systemVirusMicrobiologyMolecular GeneticsImmune systemIntegrated ControlGenome Analysis ToolsVirologyMicrobial ControlExiguaGeneticsImmune ToleranceAnimalsGene RegulationMolecular BiologyGeneBiologyImmunity to InfectionsMicrobial PathogensImmunityComputational BiologyImmune DefenseRC581-607biology.organism_classificationNucleopolyhedrovirusesParasitologyPest ControlImmunologic diseases. AllergyGenome Expression AnalysisPLoS Pathogens
researchProduct

Immune evasion, immunopathology and the regulation of the immune system.

2013

21 pages; International audience; Costs and benefits of the immune response have attracted considerable attention in the last years among evolutionary biologists. Given the cost of parasitism, natural selection should favor individuals with the most effective immune defenses. Nevertheless, there exists huge variation in the expression of immune effectors among individuals. To explain this apparent paradox, it has been suggested that an over-reactive immune system might be too costly, both in terms of metabolic resources and risks of immune-mediated diseases, setting a limit to the investment into immune defenses. Here, we argue that this view neglects one important aspect of the interaction…

Microbiology (medical)medicine.medical_treatmentlcsh:MedicineReviewBiologymedicine.disease_causehygiene hypothesisAutoimmunity03 medical and health sciences0302 clinical medicineImmune systemHygiene hypothesisImmunopathologymedicineImmunology and Allergy[ SDV.IMM ] Life Sciences [q-bio]/Immunologymolecular mimicryMolecular Biology030304 developmental biologyimmune evasion0303 health sciencesNatural selectionimmunosuppressionGeneral Immunology and Microbiologylcsh:Rautoimmunityimmune regulationImmunosuppressionbiochemical phenomena metabolism and nutritionEvasion (ethics)Molecular mimicryInfectious DiseasesImmunology[SDV.IMM]Life Sciences [q-bio]/ImmunologyTreg cells030215 immunology
researchProduct